Cited by 253Smoking Behavior and CessationPharmacogenetics and Drug MetabolismNeurotransmitter Receptor Influence on Behavior

The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.

Monoamine Oxidase and Cigarette Smoking

Fowler, Joanna S., Logan, Jean, Wang, Gene-Jack, Volkow, Nora D.·2003·NeuroToxicology

DOI 10.1016/s0161-813x(02)00109-2

Open this paper in CoChat — free account

Abstract

Current cigarette smokers have reduced monoamine oxidase (MAO) and there is evidence that this is a pharmacological effect of tobacco smoke exposure rather than a biological characteristic of smokers. This article summarizes human and animal studies documenting the inhibitory effects of tobacco smoke on MAO and discusses MAO inhibition in the context of smoking epidemiology, MAO inhibitor compounds in tobacco, reinvestigations of low platelet MAO in psychiatric disorders and smoking cessation.

Integrity signals

Registry

Crossref · 10.1016/s0161-813x(02)00109-2

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
Schildkraut, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,568
Some observations upon a new inhibitor of monoamine oxidase in brain tissue
Johnston, J. P. (1968) · Biochemical Pharmacology · doi:10.1016/0006-2952(68)90066-x · Cited by 1,597
MONOAMINE OXIDASE: From Genes to Behavior
Shih, J. C., Chen, K., & Ridd, M. J. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.197 · Cited by 1,235
Smoking, smoking cessation, and major depression
Glassman, A. H. (1990) · JAMA · doi:10.1001/jama.1990.03450120058029 · Cited by 1,207
Prevalence of smoking among psychiatric outpatients
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.8.993 · Cited by 1,058
Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors
Heikkila, R. E., Manzino, L., Cabbat, F. S., & Duvoisin, R. C. (1984) · Nature · doi:10.1038/311467a0 · Cited by 1,010
Pharmacologic Aspects of Cigarette Smoking and Nicotine Addiction
Oates, J. A., Wood, A. J. J., & Benowitz, N. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811173192005 · Cited by 969
cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties.
Bach, A. W., Lan, N. C., Johnson, D. L., Abell, C. W., Bembenek, M. E., Kwan, S. W., SEEBURG, P. H., & Shih, J. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.13.4934 · Cited by 725
Inhibition of monoamine oxidase B in the brains of smokers
Fowler, J. S., Volkow, N. D., Wang, G., Pappas, N. R., Logan, J., MacGregor, R. R., Alexoff, D. L., Shea, C. E., Schlyer, D. J., Wolf, A. P., et al. (1996) · Nature · doi:10.1038/379733a0 · Cited by 657
Self-citation

Show all 73 references

Research works printed but not linked: 3

Brauer LH, Paxton DA, Rose JE. Selegiline and transdermal nicotine for smoking cessation. In: Proceedings of the Sixth Annual Meeting of the Society for Research on Nicotine and Tobacco, Feb 18–20, Arlington, VA. 2000.
Jossan, 1987, Is monoamine oxidase B activity rate limiting for MPTP neurotoxicity?, Biogenic. Amines, 4, 371
Pavlin R, Sket D. Effect of cigarette smoke on brain monoamine oxidase activity, Farmacevtski Vestnik 1993;44:185–92.

Sorted by citations

Nicotine addiction
Benowitz, N. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0809890 · Cited by 1,508
Imaging dopamine's role in drug abuse and addiction
Volkow, N. D., Fowler, J. S., Wang, G. J., Baler, R., & Telang, F. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.022 · Cited by 988
Self-citation
Drug addiction: the neurobiology of behaviour gone awry
Volkow, N. D., & Li, T. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1539 · Cited by 638
Self-citation
Sensation Seeking And Risky Behavior
Zuckerman, M. (2006) · Choice Reviews Online · doi:10.5860/choice.45-2321 · Cited by 817
Estimating the Harms of Nicotine-Containing Products Using the MCDA Approach
Nutt, D., Phillips, L. D., Balfour, D. J. K., Curran, H. V., Dockrell, M. J., Foulds, J., Fagerström, K. O., Letlape, K., Milton, A., Polosa, R., et al. (2014) · European Addiction Research · doi:10.1159/000360220 · Cited by 439
β-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO)
Herraiz, T., González, D., Ancín-Azpilicueta, C., Arán, V. J., & Guillén, H. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.12.019 · Cited by 357
Imaging the Addicted Human Brain
Fowler, J. S., Volkow, N. D., Kassed, C. A., & Chang, L. (2007) · Science & Practice Perspectives · doi:10.1151/spp07324 · Cited by 309
Self-citation
Human monoamine oxidase is inhibited by tobacco smoke: β-carboline alkaloids act as potent and reversible inhibitors
Herraiz, T., & Chaparro, C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.033 · Cited by 258
Nicotine and brain development
Dwyer, J. B., Broide, R. S., & Leslie, F. M. (2008) · Birth Defects Research Part C: Embryo Today: Reviews · doi:10.1002/bdrc.20118 · Cited by 256
Genome-Wide and Candidate Gene Association Study of Cigarette Smoking Behaviors
Caporaso, N. E., Gu, F., Chatterjee, N., Jin, S. C., Yu, K., Yeager, M., Chen, C., Jacobs, K. B., Wheeler, W., Landi, M. T., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004653 · Cited by 252
Smoking and suicide: A brief overview
Hughes, J. R. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.06.003 · Cited by 236
The vascular effects of trace amines and amphetamines
Broadley, K. J. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.11.005 · Cited by 217
The reality of comorbidity: Depression and drug abuse
Volkow, N. D. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.007 · Cited by 218
Self-citation
Functional brain imaging of tobacco use and dependence
BRODY, A. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.04.012 · Cited by 207
A twin registry study of the relationship between posttraumatic stress disorder and nicotine dependence in men
Koenen, K. C., Hitsman, B., Lyons, M. J., Niaura, R., McCaffery, J., Goldberg, J., Eisen, S. A., True, W., & Tsuang, M. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1258 · Cited by 197
Abuse Liability Assessment of Tobacco Products Including Potential Reduced Exposure Products
Carter, L. P., Stitzer, M. L., Henningfield, J. E., O'Connor, R. J., Cummings, K. M., & Hatsukami, D. K. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0948 · Cited by 186
Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature
Philip, N. S., Carpenter, L. L., Tyrka, A. R., & Price, L. H. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1932-6 · Cited by 191
Monoamine Oxidase Expression During Development and Aging
Nicotra, A. (2003) · NeuroToxicology · doi:10.1016/s0161-813x(03)00095-0 · Cited by 181
Smoking and the Risk of Suicidal Behavior: A Prospective Study of a Community Sample
Breslau, N., Schultz, L. R., Johnson, E. O., Peterson, E. L., & Davis, G. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.3.328 · Cited by 175
Tobacco addiction and the dysregulation of brain stress systems
Bruijnzeel, A. W. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.02.015 · Cited by 181
Gateway effects and electronic cigarettes
Etter, J. (2017) · Addiction · doi:10.1111/add.13924 · Cited by 172
Monoamine oxidase and tobacco dependence
Lewis, A., Miller, J. H., & Lea, R. A. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.05.019 · Cited by 159
Role of acetaldehyde in tobacco smoke addiction
Talhout, R., Opperhuizen, A., & van Amsterdam, J. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.02.013 · Cited by 148
Human monoamine oxidase enzyme inhibition by coffee and β-carbolines norharman and harman isolated from coffee
Herraiz, T., & Chaparro, C. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.074 · Cited by 144
Epidemiologic studies of environmental exposures in Parkinson's disease
Elbaz, A., & Tranchant, C. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.06.024 · Cited by 141
New Pyrrole Inhibitors of Monoamine Oxidase: Synthesis, Biological Evaluation, and Structural Determinants of MAO-A and MAO-B Selectivity
Regina, G. L., Silvestri, R., Artico, M., Lavecchia, A., Novellino, E., Befani, O., Turini, P., & Agostinelli, E. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm060882y · Cited by 126
Effects of progression to cigarette smoking on depressed mood in adolescents: evidence from the National Longitudinal Study of Adolescent Health
Munafo, M. R., Hitsman, B. L., Rende, R., Metcalfe, C., & NIAURA, R. S. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.02052.x · Cited by 127
Untitled work
(2009) · PubMed · Cited by 116
Platelet Monoamine Oxidase, Personality and Alcoholism: The Rise, Fall and Resurrection
Oreland, L. (2003) · NeuroToxicology · doi:10.1016/s0161-813x(03)00115-3 · Cited by 113
Nicotine reduction revisited: science and future directions
Hatsukami, D. K., Perkins, K. A., LeSage, M. G., Ashley, D. L., Henningfield, J. E., Benowitz, N. L., Backinger, C. L., & Zeller, M. (2010) · Tobacco Control · doi:10.1136/tc.2009.035584 · Cited by 109
Smoking predicts posttraumatic stress symptoms among rescue workers: a prospective study of ambulance personnel involved in the Enschede Fireworks Disaster
van der Velden, P. G., Kleber, R. J., & Koenen, K. C. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.11.001 · Cited by 108
Advances in pharmacotherapy for tobacco dependence
Foulds, J., Burke, M. V., Steinberg, M. B., Williams, J. M., & Ziedonis, D. M. (2004) · Expert Opinion on Emerging Drugs · doi:10.1517/eoed.9.1.39.32951 · Cited by 108
Imbalance between drug and non-drug reward availability: A major risk factor for addiction
Ahmed, S. H. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.09.036 · Cited by 112
New mechanisms and perspectives in nicotine withdrawal
Jackson, K. J., Muldoon, P. P., Biasi, M. D., & Damaj, M. I. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.009 · Cited by 109
Smoking predicts suicidality: Findings from a prospective community study
Bronisch, T., Höfler, M., & Lieb, R. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.10.010 · Cited by 98
The Neuronal Pathways Mediating the Behavioral and Addictive Properties of Nicotine
Balfour, D. J. K. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-69248-5_8 · Cited by 99
Rodent models of nicotine reward: What do they tell us about tobacco abuse in humans?
O’Dell, L. E., & Khroyan, T. V. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.12.011 · Cited by 100
Genetics of nicotine dependence and pharmacotherapy
Lessov‐Schlaggar, C. N., Pergadia, M. L., Khroyan, T. V., & Swan, G. E. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.018 · Cited by 97
In vivo Brain Imaging of Human Exposure to Nicotine and Tobacco
Sharma, A., & Brody, A. L. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_6 · Cited by 90
Perspectives on MAO-B in Aging and Neurological Disease: Where Do We Go From Here?
Kumar, M. J., & Andersen, J. K. (2004) · Molecular Neurobiology · doi:10.1385/mn:30:1:077 · Cited by 92
Tobacco smoke exposure induces nicotine dependence in rats
Small, E., Shah, H. P., Davenport, J. J., Geier, J. E., Yavarovich, K. R., Yamada, H., Sabarinath, S., Derendorf, H., Pauly, J. R., Gold, M. S., et al. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1716-z · Cited by 85
The effect of smoking on MAOA promoter methylation in DNA prepared from lymphoblasts and whole blood
Philibert, R. A., Beach, S. R. H., Gunter, T. D., Brody, G. H., Madan, A., & Gerrard, M. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31031 · Cited by 80
Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: Implications for drug development
Janhunen, S. K., & Ahtee, L. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.09.008 · Cited by 83
Translational neuroimaging: positron emission tomography studies of monoamine oxidase
Fowler, J. S., Logan, J., Volkow, N. D., & Wang, G.-J. (2005) · Molecular Imaging and Biology · doi:10.1007/s11307-005-0016-1 · Cited by 81
Self-citation
Smoking cessation and depression: current knowledge and future directions
Wilhelm, K. A., Wedgwood, L., Niven, H., & KAY‐LAMBKIN, F. J. (2006) · Drug and Alcohol Review · doi:10.1080/09595230500459560 · Cited by 81
A mechanistic hypothesis of the factors that enhance vulnerability to nicotine use in females
O’Dell, L. E., & Torres, O. V. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.055 · Cited by 78
Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania
Berk, M., Ng, F., Wang, W. V., Tohen, M., Lubman, D. I., Vieta, E., & Dodd, S. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.01.018 · Cited by 72
Non-Nicotinic Therapies for Smoking Cessation
Siu, E. C. K., & Tyndale, R. F. (2007) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105354 · Cited by 69
Biomonitoring of inhaled complex mixtures – Ambient air, diesel exhaust and cigarette smoke
Scherer, G. (2005) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2005.05.007 · Cited by 68
Monoamine oxidase: radiotracer chemistry and human studies.
Fowler, J., Logan, J., Shumay, E., Alia-Klein, N., Wang, G.-J., & Volkow, N. (2015) · Journal of labelled compounds & radiopharmaceuticals · doi:10.1002/jlcr.3247 · Cited by 67
Self-citation
Analysis of monoamine oxidase enzymatic activity by reversed-phase high performance liquid chromatography and inhibition by β-carboline alkaloids occurring in foods and plants
Herraiz, T., & Chaparro, C. (2005) · Journal of Chromatography A · doi:10.1016/j.chroma.2005.12.009 · Cited by 59
Historical and current perspective on tobacco use and nicotine addiction
Dani, J. A., & Balfour, D. J. K. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.05.001 · Cited by 68
Examining the effect of smoking on suicidal ideation and attempts: triangulation of epidemiological approaches
Harrison, R., Munafo, M. R., Smith, G. D., & Wootton, R. E. (2020) · The British Journal of Psychiatry · doi:10.1192/bjp.2020.68 · Cited by 60
Persistent heavy smoking as risk factor for major depression (MD) incidence – Evidence from a longitudinal Canadian cohort of the National Population Health Survey
Khaled, S. M., Bulloch, A. G. M., Williams, J. V. A., Hill, J. C., Lavorato, D. H., & Patten, S. B. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.11.011 · Cited by 60
8.3 Imaging Dopamine’s Role in Drug Abuse and Addiction
Volkow, N. D., Fowler, J. S., Wang, G., Telang, F., & Baler, R. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195373035.003.0028 · Cited by 58
Self-citation
Suicidality in Opioid‐Dependent Subjects
Trémeau, F., Darreye, A., Staner, L., Corrêa, H., Weibel, H., Khidichian, F., & Macher, J. P. (2008) · American Journal on Addictions · doi:10.1080/10550490802020160 · Cited by 56
Monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity in combat-related posttraumatic stress disorder
Pivac, N., Knežević, J., Kozarić‐Kovačić, D., Deželjin, M., Mustapić, M., Rak, D., Glavan, T. M., Pavelić, J., & Mück‐Šeler, D. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.01.017 · Cited by 56
Contribution of monoamine oxidase (MAO) inhibition to tobacco and alcohol addiction
van Amsterdam, J., Talhout, R., Vleeming, W., & Opperhuizen, A. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.06.010 · Cited by 55
A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorder
Dodd, S., Brnabic, A. J. M., Berk, L., Fitzgerald, P. B., de Castella, A. R., Filia, S., Filia, K., Kelin, K., Smith, M., Montgomery, W. S., et al. (2010) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2009.12.001 · Cited by 55
The Relation between Nicotine Dependence and Suicide Attempts in the General Population
Yaworski, D., Robinson, J., Sareen, J., & Bolton, J. M. (2011) · The Canadian Journal of Psychiatry · doi:10.1177/070674371105600306 · Cited by 53
MAO-B Inhibitors Do Not Block In Vivo Flortaucipir([18F]-AV-1451) Binding
Hansen, A. K., Brooks, D. J., & Borghammer, P. (2018) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1143-1 · Cited by 51
Electrochemical investigation into the redox activity of Fe(II)/Fe(III) in the presence of nicotine and possible relations to neurodegenerative diseases
Bridge, M. H., Williams, E., Lyons, M. E. G., Tipton, K. F., & Linert, W. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.05.007 · Cited by 52
Classifying smoking urges via machine learning
Dumortier, A., Beckjord, E. B., Shiffman, S. S., & Sejdić, E. (2016) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2016.09.016 · Cited by 49
Effects of high dose transdermal nicotine replacement in cigarette smokers
Hatsukami, D. K., Mooney, M. E., Murphy, S. E., LeSage, M. G., Babb, D. A., & Hecht, S. S. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.12.017 · Cited by 47
Methylphenidate Enhances the Abuse-Related Behavioral Effects of Nicotine in Rats: Intravenous Self-Administration, Drug Discrimination, and Locomotor Cross-Sensitization
Wooters, T. E., Neugebauer‎, N. M., Rush, C. R., & Bardo, M. T. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301477 · Cited by 47
Psychological distress is associated with tobacco smoking and quitting behaviour in the Australian population: evidence from National Cross-Sectional Surveys
Leung, J., Gartner, C., Dobson, A., Lucke, J., & Hall, W. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2010.534070 · Cited by 46
New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?
Beard, E., Shahab, L., Cummings, D. M., Michie, S., & West, R. (2016) · CNS Drugs · doi:10.1007/s40263-016-0362-3 · Cited by 44
Tobacco particulate matter self‐administration in rats: differential effects of tobacco type
Brennan, K. A., Crowther, A., Putt, F., Roper, V., Waterhouse, U., & Truman, P. (2013) · Addiction Biology · doi:10.1111/adb.12099 · Cited by 47
Contribution of Monoamine Oxidase Inhibition to Tobacco Dependence: A Review of the Evidence
Hogg, R. C. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntv245 · Cited by 43
An updated patent review on monoamine oxidase (MAO) inhibitors
Guglielmi, P., Carradori, S., D’Agostino, I., Campestre, C., & Petzer, J. P. (2022) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2022.2083501 · Cited by 42
Monoamine Oxidase Inhibitors—Revisiting a Therapeutic Principle
Entzeroth, M., & Ratty, A. K. (2017) · Open Journal of Depression · doi:10.4236/ojd.2017.62004 · Cited by 42
Smoking Is Associated with Pain in All Body Regions, with Greatest Influence on Spinal Pain
Smuck, M. W., Schneider, B. J., Ehsanian, R., Martin, E. N., & Kao, M. J. (2019) · Pain Medicine · doi:10.1093/pm/pnz224 · Cited by 43
Monoamine Oxidase Inhibition for Tobacco Pharmacotherapy
George, T., & Weinberger, A. H. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100474 · Cited by 42
A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers☆
Weinberger, A. H., Reutenauer, E. L., Jatlow, P. I., O’Malley, S. S., Potenza, M. N., & George, T. P. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.10.009 · Cited by 41
Neuropharmacology of the Interoceptive Stimulus Properties of Nicotine
Wooters, T. E., Bevins, R. A., & Bardo, M. T. (2009) · Current Drug Abuse Reviews · doi:10.2174/1874473710902030243 · Cited by 42
Variations in gender ratios support the connection between smoking and Parkinson's disease
Morozova, N., O’Reilly, É. J., & Ascherio, A. (2008) · Movement Disorders · doi:10.1002/mds.22045 · Cited by 39
Tobacco and Psychiatric Dual Disorders
Graham, N. A., Frost-Pineda, K., & Gold, M. S. (2007) · Journal of Addictive Diseases · doi:10.1300/j069v26s01_02 · Cited by 38
MAO‐B knockout mice exhibit deficient habituation of locomotor activity but normal nicotine intake
Lee, M., Chen, K., Shih, J. C., & Hiroi, N. (2004) · Genes Brain & Behavior · doi:10.1111/j.1601-1848.2004.00074.x · Cited by 37
Exploring the Role of Monoamine Oxidase Activity in Aging and Alzheimer’s Disease
Rahman, M. S., Uddin, M. S., Rahman, M. A., Samsuzzaman, M., Behl, T., Hafeez, A., Perveen, A., Barreto, G. E., & Ashraf, G. M. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612827666210612051713 · Cited by 38
Suicidal Ideation, Suicidal Plan and Suicidal Attempts Among Those with Major Depressive Disorder
Subramaniam, M., Abdin, E., Seow, E., Picco, L., Vaingankar, J. A., & Chong, S. A. (2014) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v43n8p412 · Cited by 35
Genetics and Drug Use as a Complex Phenotype
Lessov, C. N., Swan, G. E., Ring, H. Z., Khroyan, T. V., & Lerman, C. E. (2004) · Substance Use & Misuse · doi:10.1081/ja-200033202 · Cited by 37
Longitudinal association between tobacco use and the onset of depressive symptoms among Swedish adolescents: the Kupol cohort study
Raffetti, E., Donato, F., Forsell, Y., & Galanti, M. R. (2018) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-018-1237-6 · Cited by 38
The Role of Mesoaccumbens Dopamine in Nicotine Dependence
Balfour, D. J. K. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13482-6_3 · Cited by 36
Reinforcing and neural activating effects of norharmane, a non-nicotine tobacco constituent, alone and in combination with nicotine
Arnold, M. M., Loughlin, S. E., Belluzzi, J. D., & Leslie, F. M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.05.035 · Cited by 37
Comparison of the binding of the irreversible monoamine oxidase tracers, [11C]clorgyline and [11C]l-deprenyl in brain and peripheral organs in humans
Fowler, J. S., Logan, J., Wang, G., Volkow, N. D., Telang, F., Ding, Y., Shea, C. E., Garza, V., Xu, Y., Li, Z., et al. (2004) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2003.10.003 · Cited by 33
Self-citation
Smoking Cessation Pharmacotherapy—Nicotine and Non‐Nicotine Preparations
Frishman, W. H. (2007) · Preventive Cardiology · doi:10.1111/j.1520-037x.2007.05963.x · Cited by 33
Inhibition effects of Vernonia cinerea active compounds against cytochrome P450 2A6 and human monoamine oxidases, possible targets for reduction of tobacco dependence
Prasopthum, A., Pouyfung, P., Sarapusit, S., Srisook, E., & Rongnoparut, P. (2015) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2014.12.005 · Cited by 32
The effect of risky alcohol use and smoking on suicide risk: findings from the German MONICA/KORA-Augsburg Cohort Study
Schneider, B., Baumert, J. J., Schneider, A. L. C., Marten‐Mittag, B., Meisinger, C., Erazo, N., Hammer, G. P., & Ladwig, K. (2010) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-010-0287-y · Cited by 32
A case‐control study of Parkinson's disease and tobacco use: Gene‐tobacco interactions
Palma, G. D., Dick, F. D., Calzetti, S., SCOTT, N. W., Prescott, G. J., Osborne, A., Kingsbury, N., Mozzoni, P., Negrotti, A., Scaglioni, A., et al. (2010) · Movement Disorders · doi:10.1002/mds.22980 · Cited by 32
The serotonin 2A receptor gene in alcohol dependence and tobacco smoking
Polina, E. R., Contini, V., Hutz, M. H., & Bau, C. H. D. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.11.001 · Cited by 31
Age influences the effects of nicotine and monoamine oxidase inhibition on mood-related behaviors in rats
Villégier, A., Gallager, B., Heston, J. B., Belluzzi, J. D., & Leslie, F. M. (2010) · Psychopharmacology · doi:10.1007/s00213-009-1760-8 · Cited by 34
Markov model of smoking cessation
Killeen, P. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011277108 · Cited by 33
A review of monoamine oxidase (MAO) inhibitors in tobacco or tobacco smoke
Hong, S. W., Teesdale‐Spittle, P. H., Page, R., & Truman, P. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.09.008 · Cited by 32
Monoamine oxidase inhibitory activity in tobacco smoke varies with tobacco type
Lewis, A. J., Truman, P., Hosking, M., & Miller, J. H. (2011) · Tobacco Control · doi:10.1136/tc.2010.040287 · Cited by 30
The lack of association between monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity among men
Pivac, N., Knežević, J., Mustapić, M., Deželjin, M., Mück‐Šeler, D., Kozarić‐Kovačić, D., Balija, M., Glavan, T. M., & Pavelić, J. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.030 · Cited by 30
Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptor TaqIB polymorphism are associated with ever-smoking status among men
Costa‐Mallen, P., Costa, L. G., & Checkoway, H. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.05.035 · Cited by 29
Enhanced smoking cue salience associated with depression severity in nicotine-dependent individuals: a preliminary fMRI study
Kushnir, V., Menon, M., Balducci, X. L., Selby, P. L., Busto, U. E., & Zawertailo, L. A. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000696 · Cited by 32
Neurobiology of Addiction
Koob, G. F., Kandel, D. B., Baler, R., & Volkow, N. D. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_29-1 · Cited by 31
Self-citation
The nicotine market: An attempt to estimate the nicotine intake from various sources and the total nicotine consumption in some countries
Fagerström, K. O. (2005) · Nicotine & Tobacco Research · doi:10.1080/14622200500124875 · Cited by 27
Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer’s disease and elderly controls after oral administration of sembragiline
Sturm, S., Forsberg, A., Navé, S., Stenkrona, P., Seneca, N. M., Varrone, A., Comley, R. A., Fazio, P., Jamois, C., Nakao, R., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3510-6 · Cited by 26

Authors: Fowler, J. S., Logan, J., Wang, G.-J., & Volkow, N. D.
Affiliations: Brookhaven National Laboratory (US)
Corresponding author: Fowler, Joanna S.
ORCID: Logan, Jean
Wang, Gene-Jack
Volkow, Nora D.
Venue: NeuroToxicology
Publisher: Elsevier BV
Published: 2003-01
Volume: 24
Issue: 1
Pages: 75-82
ISSN: 0161-813X (ISSN-L)
DOI: 10.1016/s0161-813x(02)00109-2
OpenAlex: W2138349568
Cited by: 251
References: 73
Citations by year: 2026: 1 · 2025: 5 · 2024: 5 · 2023: 4 · 2022: 9 · 2021: 5 · 2020: 29 · 2019: 5 · 2018: 9 · 2017: 9 · 2016: 9 · 2015: 9 · 2014: 13 · 2013: 9 · 2012: 8
FWCI: 5.59
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: NeuroToxicology (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Department of Energy
National Institute on Drug Abuse
Brookhaven National Laboratory
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords: monoamine oxidase, cigarette smoking, tobacco smoke, monoamine oxidase inhibition, tobacco smoke constituents, smoking cessation, mental illness
MeSH terms: Animals, Mental Disorders, Brain, Humans, Monoamine Oxidase, Monoamine Oxidase Inhibitors, Smoking, Smoking Cessation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Monoamine Oxidase and Cigarette Smoking

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks